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Human gliomas are primary neoplasms of the central nervous system that grow diffusely, show different grades of local aggressiveness and display histological and immunohistochemical features of glial lineages or less differentiated neural progenitor cells [1] [2] [3] . Although the exact cellular origin of gliomas remains unclear 2, 3 , it has been proposed that only a fraction of cancer cells with stem cell properties, usually named cancer stem cells, has true tumorigenic potential and constitutes a discrete reservoir of glioma-initiating cells 4, 5 . Glioma-initiating cells initially had been identified as CD133 + cells 6, 7 , but recent studies demonstrate a relative lack of specificity of this marker [8] [9] [10] [11] . Also, some studies have questioned the existence of a cellular hierarchy dominated by cancer stem cells in solid tumors or alternatively have shed doubt on their supposed rarity 12, 13 . Despite current controversies, there is general agreement that tumors are heterogeneous populations of cells, some of which have a superior tumor initiating and propagating ability. There is therefore a need for reliable methods to identify, isolate and characterize the entire gliomainitiating cell reservoir, even if all cells in this set do not necessarily have bona fide stem cell properties or express homogenous molecular markers. Here we show that the combination of a distinct morphology and autofluorescence emission can be used to identify a subpopulation of glioma cells with self-renewal ability in vitro and tumor-initiating and propagating capacity in vivo. Cells in this population have enhanced proliferative activity and preferentially express stem cell-related genes. By avoiding the use of molecular markers and relying on general phenotypic properties correlating with tumorigenicity, our results offer a simple approach for identifying glioma-initiating cells that might be efficiently exploited to understand the molecular mechanisms governing tumor growth.
marker-independent identification of gliomainitiating cells

resuLts
Identification of a new glioma cell subpopulation
A subpopulation of human glioma cells displays autofluorescence emission around 520 nm (in the FL1 channel) upon laser excitation at 488 nm (Supplementary Table 1 and Supplementary Fig. 1 ). Cells in this fraction, hereafter called FL1 + , can be detected both by fluorescence-activated cell sorting (FACS) or fluorescence microscopy in glioma cell cultures and in freshly dissociated glioma tissue (Fig. 1a-d and Supplementary Tables 2-4 ). All tumors are labeled according to their type and World Health Organization (WHO) grade and numbered as described in Supplementary Table 2 . The microscopic analysis of FL1 + cells confirmed that they were large agranular cells with a very high nuclear:cytoplasmic ratio (Fig. 1c) correlating with the high forward scatter and a low side scatter in the FACS analysis. In serumfree conditions (stem cell culture conditions), glioma cells form floating colonies enriched in glioma-initiating cells (gliomaspheres) 14 . Analysis of gliomasphere cultures from different tumors showed varying percentages of FL1 + cells (Supplementary Table 3 , n = 10 cultures), which remained stable over 20 passages in vitro (Supplementary Fig. 2 ). Analysis of freshly dissociated human gliomas of different malignancy grade and subtype also revealed the presence of a relatively rare FL1 + cell population ( Fig. 1c and Supplementary Table 4 ; n = 26 tissues) displaying on average lower fluorescence intensity (mean of intensity < 10 2 ) than artICLes retracted Fig. 3 ) when examined 4-8 d after plating. After 10 d of differentiation, however, cells with FL1 + characteristics could no longer be detected in cultures derived from sorted FL1 + cells, in contrast to matched FL1 + samples cultured in stem cell conditions (Fig. 1e) . The subsequent transfer of differentiated cultures into stem cell culture conditions did not reconstitute FL1 + properties such as autofluorescence or sphere formation (Fig. 1e) . Similarly, when we plated fresh glioma-derived cells in serum-rich conditions, the autofluorescent subpopulation and its spherogenic ability was irreversibly lost (Supplementary Fig. 4 ). The fact that FL1 + cells were only present in stem cell culture conditions and were lost upon induction of differentiation suggests that FL1 + cells may have properties similar to those of stem cells.
self-renewal of FL1 + cells
As self-renewal is a property of stemness in normal tissue and has also been used to characterize cancer stem cells 17 , we tested the ability of FL1 + cells to self renew in clonogenic assays. Single-cell plating of sorted FL1 + and FL1 0 cells either from fresh dissociated glioma tissues or from glioma cell cultures revealed that FL1 + cells have a superior capacity to self-renew than FL1 0 cells (Fig. 2a,b) . We then measured the self-renewal ability of individual FL1 + and FL1 0 clones over several successive cell passages. Whereas FL1 + clones retained spherogenic potential for at least five passages, Table 5 ). FL1 + spheres were larger, floating and apparently healthier than the partially attached and undersized FL1 0 clones (Fig. 2d) . Moreover, FL1 0 derived clones did not contain any FL1 + cells, whereas isolated FL1 + cells could generate both FL1 + and FL1 0 cells in passaged gliomaspheres (Supplementary Fig. 5 ).
expression of stemness-related genes in FL1 + cells
Several stem-cell and progenitor-cell gene expression profiles have been identified in gliomas or glioma-initiating cells [18] [19] [20] .
To understand the molecular mechanisms underlying the selective stemness phenotype of FL1 + glioma cells, we quantified the expression of 14 selected 18 stemness-related genes in FL1 + and FL1 0 cells from four different gliomas. The only genes expressed more than twofold in FL1 + cells were NANOG, POU5F1 (also known as OCT4), SOX2 and NOTCH1 (Fig. 3a and Supplementary Table 6 ). FACS and confocal imaging analysis of stemness-related proteins corresponding to the above-mentioned genes revealed a preferential but not exclusive expression in FL1 + cells (Fig. 3b,c and Supplementary Fig. 6 ). Although the majority of KI67 + cells were confined to the FL1 + cell fractions, FL1 0 cells also expressed KI67 (Fig. 3b,c and Supplementary Fig. 6f ), suggesting that FL1 0 cells were viable and proliferated to some extent. We found a relatively low percentage of CD133 + cells in both FL1 0 and FL1 + cell compartments (Fig. 3d, Supplementary Fig. 7 and Supplementary Table 7) . Conversely, sorted CD133 + cells were distributed in both FL1 0 and FL1 + cell compartments ( Fig. 3e and 
Supplementary Table 8). Statistical analysis (paired t-test)
of the percentage of FL1 + cells and CD133 + cells as determined by FACS in fresh primary glioblastoma multiforme (P = 0.69, R 2 = 0.094, n = 4) and gliomasphere cultures (P = 0.58, R 2 = 0.094, n = 5) confirmed that there was no correlation between the FL1 + phenotype and the expression of CD133, suggesting that CD133 alone might not be sufficient to fractionate cancer-initiating and non-cancer-initiating cells.
FL1 + cells were tumorigenic in vivo
To test whether glioma-initiating cells originated only from the FL1 + population, we intracranially injected sorted FL1 + or FL1 0 cells from fresh tissue or from two primary and one secondary glioblastoma multiforme-derived gliomasphere cultures (Figs. 4 and 5 and Supplementary Table 9 ). When cells to be injected were isolated from gliomasphere cultures, all mice injected with FL1 + cells, even with a load of 10 3 cells, exhibited substantial weight loss and neurological symptoms within few weeks, correlating with intracranial tumors observed on magnetic resonance images and histological sections (Fig. 4 and Supplementary Fig. 8 ). We detected no tumors in FL1 0 cell-injected mice even at a 10 5 intracranial cell load after more than three months (Supplementary Table 9 ), except for one experiment, which subsequently revealed the presence of FL1 + cells, potentially because of a residual contamination of FL1 + cells during FACS. Upon injection of cells obtained from fresh glioma, only the mice implanted with the FL1 + cells developed neurological symptoms by four months, which correlated with a massive infiltrative glioma (Fig. 5) . Serial transplantation of freshly isolated FL1 + cells confirmed that the tumorigenic potential was exclusively confined to the FL1 + cell population (Supplementary Table 10) . Implantation of as few as 3,000 FL1 + cells was sufficient to initiate tumorigenesis within three months (data not shown). On histological sections, FL1 + cell-induced tumors showed FL1 autofluorescence and contained a higher proportion of NESTIN + and KI67 + cells compared to GFAP + , TUJ1 + cells (Fig. 5b and Supplementary Fig. 8) . The human origin of the tumors was confirmed by human MHC-I staining (Supplementary Fig. 9 ). When we analyzed brains of injected mice after dissociation, we found FL1 + cells only in FL1 + cell-injected brains (Supplementary Fig. 9 ). Plating of dissociated cells resulted in the formation of many large spheres from FL1 + tumors within 2 or 3 d, in contrast to cultures derived from FL1 0 cell-injected brains (Supplementary Fig. 9 ). These data suggest that a selection strategy based on phenotype can identify, in both glioma and glioma cultures, a subpopulation of glioma cells with exclusive in vivo tumorigenic potential.
dIsCussIon
Our data suggest that self-renewing and tumor-initiating glioma cells have a distinct morphology and autofluorescence, which allows their identification and isolation from non-tumorigenic glioma cells independently of CD133. FL1 + cells were enriched for stemness-related genes, were multipotent, could generate FL1 0 cells and could self-renew over time (Supplementary Fig. 10) . Moreover, as clonal gliomaspheres derived from FL1 + cells contained a mixed population of FL1 + and FL1 0 cells, FL1 0 cells should logically be derived from FL1 + cells either by asymmetric division or by loss of properties associated with autofluorescence in some FL1 + cells. Because FL1 0 cell-derived cultures did not yield any FL1 + cells, FL1 0 cells may be committed tumor progenitors or differentiating cells that have lost their self-renewal and tumorigenic properties. We are currently studying the differentiation potential of FL1 0 cells. They are not cancer-initiating cells as they unambiguously do not have long-term self-renewal properties in vitro and are not tumorigenic in vivo. However, when plated under conditions that promote differentiation, FL1 0 cells expressed differentiation markers, as did FL1 + cells under similar culture conditions. Thus the FL1 0 population may include progenitor cells in addition to more differentiated cancer cells.
We do not yet understand the molecular basis of the autofluorescence in FL1 + cells. Several studies have linked autofluorescence with the cell cycle and/or cellular metabolic activity, such as the intracellular NAD/NADPH status or mitochondrial flavin content [21] [22] [23] . Our preliminary data suggest that autofluorescence in FL1 + cells may reflect higher metabolic and proliferative activity (data not shown). In this respect, the relatively low autofluorescence levels and rarity of the FL1 + population in vivo, relative to what we observed in in vitro culture, may indicate a more quiescent state of FL1 + cells when growing in their natural tumor environment with lower oxygen levels, growth factor supply and glucose concentrations than those present in vitro.
Present knowledge of other normal and cancer tissues such as the hematopoietic system indicates that stem cells or early progenitor populations are rarely defined by only one but rather artICLes retracted by a combination of molecular markers 24 . Notably, none of the stemness genes (including CD133) that potentially could be used as a functional cancer stem cell marker, was exclusively restricted to the FL1 + population as expression of all tested genes was also detectable in FL1 0 cells. Moreover, 'stemness', and in particular cancer stemness, might well be an elusive property that is not defined by invariable molecular markers but may have less stable molecular configurations that change with time and environmental context 12, 13, [25] [26] [27] . Differences between TICs and other tumor cells may not be as clear-cut as in normal tissues, in which a stringent hierarchy and strictly balanced asymmetric division guarantees tissue integrity 28, 29 . As they are genetically altered, cancers might contain a spectrum of 'intermediate' tumor cells with various tumorigenic potencies and more or less aberrant differentiation states 3, 26 . It may therefore be possible to consider cancer stemness in a given subpopulation or in single cells as a property with variable expressivity rather than a strictly committed on or off state with obligatory expression of defined markers. Altogether, our data show that a subpopulation of glioma cells have an identifiable cellular phenotype strongly correlated with stemness and tumorigenic capacity and can be isolated without the use of molecular markers. Exploiting these properties may be more suitable to capture the dynamic complexity of tumor initiating cells and allow the identification of new therapeutic targets. 4, 8 . Media and growth factors were renewed once a week. Primary spheres are those spheres formed after fresh isolation of cells from tumors. Secondary spheres are the second generation of spheres generated from dissociated primary spheres. Sphere formation was assessed as reported 18 and presented as the percentage of clones derived from the initial number of cells plated. Selfrenewal ability was monitored by dissociating spheres mechanically and transferring dissociated cells along successive passages as described previously 8 . Differentiation assays were performed as described previously 15 .
FACS analysis of cells using morphology, autofluorescence and CD133 staining. Fresh glioma cells or dissociated cells from gliomaspheres cultures were adjusted at a concentration of 1 million cell per ml in 1× PBS (pH 7.4) before analysis or sorting either on Beckton Dickinson FACScan or FACSVantage or AriA (BD Bioscience). In gliomasphere cultures, FL1 + cells were selected using the intersection of P1 and P4 and FL1 0 cells were selected using the intersection of P2 and P5 as shown in Figure 1a .
For sorting from fresh glioma, the morphology and relatively low levels of fluorescence of the cells were taken into account for adjusting the gating by also incorporating cells with lower FL1 signal after selecting for appropriate morphology (low SSC and high FSC), that is, FL1 + were selected using the intersection of P1 and P3 and FL1 0 were selected using the intersection of P2 and P5 (Fig. 1c) . Characteristics of FL1 autofluorescence were evaluated by excitation with additional lasers at different wavelengths: 488 nm (Can, Vantage), 532 nm (Aria) 546 nm (Sorter), 632 nm (Calibur) (Supplementary Table 1 and Supplementary Fig. 1 ). CD133 staining and expression level analyses were performed as described previsouly 8 . Cell viability was tested by addition of trypan blue (Sigma) at 1/1,000 dilution. FACS data analysis was performed using CellQuest and Diva software.
Statistical analyses. Paired t-test, correlation and linear regression were done using GraphPad Prism. Experiments were carried out in triplicate for each assay on each individual gliomasphere culture mentioned.
